Cell Washing and Concentration System

What is the Cell Washing and Concentration System?

A cell washing and concentration system removes medium, beads and impurities from a cell product and reduces it to a defined dose volume in a closed circuit. It is used at the end of cell therapy manufacturing before formulation and fill.

Overview

A cell washing and concentration system moves a cell suspension through a single-use processing set that separates cells from liquid. Some designs use a spinning chamber or a flexible diaphragm to concentrate cells by centrifugation, while others use tangential flow filtration across a hollow-fibre or flat membrane. Supernatant containing medium, residual beads, cytokines and debris is expressed to a waste bag, and the cells are resuspended in a wash or formulation buffer. The operator sets the final volume, the number of wash cycles and, in some systems, the cryoprotectant addition step, all within a closed, sterile path. Recovery and viability are monitored after processing, and the process record captures volumes, times and operator identity. These systems reduce open handling and manual centrifugation, improving consistency and safety for autologous products.

How does it work?

Cell processing equipment manipulates living cells while preserving viability and function. Separation and selection use immunomagnetic beads or density gradients to enrich a target population. Activation with antibodies or cytokines prepares T cells or other lymphocytes for expansion, which is then carried out in closed, gas-permeable culture systems with controlled temperature, dissolved oxygen and feeding. Washing and concentration use centrifugation in a closed chamber or tangential flow filtration to remove medium, beads and impurities and to reach a defined dose volume. Formulation adds a cryoprotectant such as dimethyl sulfoxide before controlled-rate freezing stores the product at low temperature. Because the product is living and often autologous, the equipment is designed for closed processing, single-use fluid paths, low shear and full traceability of each patient batch.

What are the key features?

• Closed single-use processing set
• Centrifugal or membrane-based separation
• Programmable wash cycles and final volume
• Optional in-circuit cryoprotectant addition
• Process record with volumes, times and operator identity

What are the technical specifications?

A typical cell washing and concentration system configuration offers processing volume of 10 mL–20 L, final volume of 5–500 mL (user set), cell recovery of Typically above 70–90%, separation method of Centrifugal chamber or TFF membrane, wash cycles of Programmable, 1–5 and flow path of Closed, single-use, sterile. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Cell Washing and Concentration System is used in cell therapy final formulation, bead removal after selection, buffer exchange before cryopreservation and concentration of expanded cells. Across the wider Cell Processing class, laboratories also deploy it for autologous cell therapy manufacturing, allogeneic cell product manufacturing and CAR-T and TCR cell production.

Which standards and certifications apply?

Relevant standards and methods include EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11, 21 CFR Part 1271, ISO 13485, USP <1046> and IEC 61010-1. Certification candidates for this model are CE, ISO 13485 manufacturing and IEC 61010-1 compliance; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Handle all materials under the appropriate biosafety and cleanroom conditions, and use aseptic technique throughout. Verify that reagents and consumables are qualified for the process and that lot changes are controlled. Confirm closed-system integrity, especially connectors and welds, and monitor cell counts, viability and sterility at defined points. Programmable steps should be locked and version controlled, and each patient or batch record should capture operator, reagents and deviations. Maintain temperature control and check that shear and centrifugation settings do not reduce viability. For regulated production, validate the process, qualify the equipment and confirm that software meets data integrity requirements. Electrical safety follows IEC 61010-1.

How do I select the right Cell Washing and Concentration System?

Choose a closed washing and concentration system when autologous product handling and dose-volume accuracy matter. In an RFQ specify processing and final volumes, separation method, wash cycle options, cryoprotectant addition, recovery performance and the batch record and traceability features required.

How does it compare with other Cell Processing variants?

Select equipment from the cell type, the target dose and the closedness your product requires. Autologous therapies need single-use, closed fluid paths that avoid open manipulation, so specify bag and connector formats and whether processing is manual, semi-automated or fully automated. For selection, choose immunomagnetic or density-based methods according to the required purity, recovery and whether the target is rare. For expansion, match the culture surface area, gas exchange and feeding strategy to the expected fold expansion and cell density. For washing and concentration, define the final dose volume, acceptable recovery and whether a cryoprotectant must be added in the same closed circuit. Confirm traceability, batch records and validation support, and check that the system fits your cleanroom grade and operator workflow.